SCHEMBL23016252

SCHEMBL23016252

c1cnc2c(-c3ccc4cc(-c5ccc6nc(-c7ccc(-c8ccc9ccc%10cccnc%10c9n8)cc7)ccc6c5)ccc4n3)cccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
POLB P06746 1/20 0.49
CYP3A4 P08684 3/20 0.43
LMNA P02545 2/20 0.43
CYP2D6 P10635 2/20 0.43
KDM4E B2RXH2 2/20 0.43
GMNN O75496 2/20 0.43
TP53 P04637 2/20 0.43
MAPT P10636 2/20 0.43
CCR1 P32246 2/20 0.43
THPO P40225 2/20 0.43
CCR5 P51681 2/20 0.43
CCR8 P51685 2/20 0.43
PMP22 Q01453 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HSP90AA1 P07900 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24475561 0.96 NPC1 (0.45) NPC1RAB9APOLBCYP3A4LMNA
SCHEMBL23016310 0.96 TOP1 (0.48) NPC1RAB9APOLBCYP3A4LMNA
SCHEMBL23016223 0.96 NPC1 (0.47) NPC1RAB9APOLBCYP3A4LMNA
SCHEMBL23016201 0.95 NPC1 (0.46) NPC1RAB9APOLBCYP3A4LMNA
SCHEMBL18943843 0.93 TOP1 (0.50) NPC1RAB9APOLBCYP3A4LMNA
SCHEMBL24475564 0.92 NPC1 (0.44) NPC1RAB9APOLBCYP3A4LMNA
SCHEMBL23016315 0.92 NPC1 (0.54) NPC1RAB9APOLBCYP3A4LMNA
SCHEMBL22282027 0.91 NPC1 (0.43) NPC1RAB9APOLBCYP3A4LMNA
SCHEMBL23016222 0.91 NPC1 (0.45) NPC1RAB9APOLBCYP3A4LMNA
SCHEMBL23016242 0.91 NPC1 (0.47) NPC1RAB9APOLBCYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10930857-B2 Heterocyclic compound and organic light emitting device using same LT MATERIALS CO., LTD. (KR) 2021-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10930857-B2 Heterocyclic compound and organic light emitting device using same CRY1, CRY2, CYBA NPC1 4299/4885RAB9A 3913/4885POLB 699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.